Literature DB >> 28089092

Treatment of de novo hepatitis C virus-related fibrosing cholestatic hepatitis after orthotopic heart transplantation by ledipasvir and sofosbuvir.

Chen-Hua Liu1, Yih-Sharng Chen2, Sheoi-Shen Wang2, Jia-Horng Kao3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28089092     DOI： 10.1016/j.jfma.2016.12.005

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN： 0929-6646            Impact factor:   3.282


× No keyword cloud information.
  2 in total

1.  Heart Transplantation From Hepatitis C-Positive Donors in the Era of Direct Acting Antiviral Therapy: A Comprehensive Literature Review.

Authors:  Schnegg Bruno; Bart Nicole; Dharan Nila J; Matthews Gail; Nadel James; Macdonald Peter S; Hayward Christopher S
Journal:  Transplant Direct       Date:  2019-08-23

2.  Hepatic Failure Due to Cholestatic Hepatitis C in an Immunosuppressed Patient Treated With Elbasvir and Grazeprevir.

Authors:  Amin H Nassar; Baraa M Abdul-Jawad; David S Barnes
Journal:  ACG Case Rep J       Date:  2018-01-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.